The Blind Spots Boards Miss When Entering Regulated Markets

Most failed market entries in regulated sectors do not fail because the strategy was wrong. They fail because the board approved a plan built on assumptions that no external stakeholder had ever confirmed. By the time the gap becomes visible, capital is committed, timelines are public, and the cost of retreat is higher than the cost of pushing through a weakened position.

Here are the blind spots that recur, why they persist, and what to do about them.

The regulator's silence is read as consent

Boards routinely treat the absence of regulator objection as tacit approval. It is not. Regulators rarely pre-approve strategies they have not been formally asked to assess, and their private tone in early meetings is almost always more encouraging than their written position will be once a licence application or change-in-control notification lands.

What good looks like: separate what the regulator has actually said in writing from what your team believes they meant. If the distinction is uncomfortable, you have found the blind spot.

The incumbent reaction is modelled too gently

Entry plans typically assume incumbents will respond rationally and slowly. In regulated sectors, incumbents have access to the same regulators, industry bodies, and political channels you do, and they use them. Expect coordinated technical objections dressed as consumer protection concerns, quiet briefings against your model, and selective pricing responses in the segments you most need to win.

Boards underestimate this because their competitive intelligence comes from consultants who benchmark markets, not from people who have sat across the table from the specific incumbents involved.

Political exposure is treated as a communications problem

In banking, insurance, and asset management, political risk is structural, not reputational. A minister, shadow minister, select committee chair, or consumer champion can reshape the economics of your entry with a single intervention. Boards often discover this only after approval, when public affairs is asked to "manage" a position that should have been tested six months earlier.

The test: can your public affairs lead name the three people most likely to intervene against your entry, and describe what each of them has said publicly in the last twelve months? If not, the political read is not done.

Consumer and civil society positions are assumed, not verified

Consumer bodies, debt charities, ombudsman services, and specialist NGOs shape regulator thinking more than most boards recognise. Their positions are knowable in advance. They are rarely asked. The blind spot is not that these groups are hostile, it is that their concerns often align with regulator concerns, and hearing them early lets you adjust the proposition before it hardens.

Distribution partners hedge quietly

In regulated markets, distribution partners, platforms, IFAs, brokers, custodians, are the ones who translate strategy into flows. They will tell you they support your entry in the room. They will also tell your competitor the same thing. Verified partner intent means signed heads of terms, exclusivity clauses, or documented volume commitments. Anything less is a hope, not a plan.

Internal advocates crowd out disconfirming views

The executive sponsor of a market entry has strong incentives to filter what reaches the board. This is not dishonesty, it is gravity. External validation exists precisely to counteract it. If the only people telling the board this entry will work are the people whose careers depend on it working, the board has a governance problem, not just an information problem.

What to do before the next capital decision

Before the paper goes to the board, insist on three things:

1. A written summary of the external stakeholder positions on the entry, sourced from direct conversations conducted by someone without a stake in the outcome. Regulator, two incumbents, two political figures, two consumer or industry bodies, two distribution partners. Minimum.

1. An explicit list of the assumptions in the business case that depend on stakeholder behaviour, and the evidence base for each. Where the evidence is "management judgement," mark it.

1. A pre-mortem: if this entry fails within twenty-four months, which stakeholder position will have been the cause? If the room cannot answer, the validation work is not done.

The decision point is simple. Either the external positions have been tested by someone independent, or they have not. If they have not, the board is not approving a strategy. It is approving a hypothesis.